Angiomyolipoma
MONDO:0002603A neoplasm with perivascular epithelioid cell differentiation often associated with tuberous sclerosis. It is characterized by a mixture of epithelioid cells, smooth muscle, vessels, and mature adipose tissue. The kidney is the most common site of involvement. Other sites of involvement include the liver, lung, lymph nodes, and retroperitoneum. The vast majority of cases follow a benign clinical course. However, cases of metastatic angiomyolipomas with sarcomatoid features have been described.
Also known as: angiomyolipoma (morphologic abnormality)
1447 clinical trials for this condition and its sub-types, 4 tagged with Angiomyolipoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Angiomyolipoma
-
Kidney angiomyolipoma 4 trials
1 sub-type
- Childhood kidney angiomyolipoma 0 trials
-
Epithelioid type angiomyolipoma 0 trials
-
Hepatic angiomyolipoma 0 trials
-
New study tests everolimus for kidney tumors in TSC patients
Disease control OngoingThis study looks at how safe and effective the drug everolimus is for Taiwanese adults with tuberous sclerosis complex (TSC) who have kidney tumors called angiomyolipomas. Four participants will take the drug and be monitored for side effects and tumor shrinkage. The goal is to c…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New procedure aims to shrink kidney tumors without surgery
Disease control OngoingThis study tests a minimally invasive procedure that blocks blood flow to kidney angiomyolipomas (non-cancerous tumors). The goal is to shrink the tumors and stop bleeding while preserving kidney function. Researchers will follow 50 patients for one year to check safety and effec…
Sponsor: Botkin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New device aims to starve tumors by cutting off their blood supply
Disease control OngoingThis study tests a device called GPX that blocks blood flow to tumors or other targeted areas. About 114 adults with conditions like kidney tumors or bone tumors will receive the treatment. The goal is to see if the device is safe and works well at reaching and blocking small blo…
Sponsor: Fluidx Medical Technology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New MRI method may spare kidney patients unnecessary biopsies
Diagnosis OngoingThis study tests whether a special MRI can tell the difference between harmless and cancerous kidney growths when standard CT scans cannot see fat. About 44 adults with kidney masses that have no visible fat on CT will get this advanced MRI. The goal is to see if the MRI can iden…
Sponsor: Chang Gung Memorial Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC